+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gastrointestinal Cancer"

From
From
From
From
From
From
From
From
Cancer Cachexia Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cancer Cachexia Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 145 Pages
  • Global
From
From
Pipeline of EpCAM-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of EpCAM-Targeted Immunotherapies

  • Report
  • November 2025
  • Global
From
From
Loading Indicator

Gastrointestinal cancer is a type of cancer that affects the digestive system, including the stomach, small intestine, colon, rectum, liver, gallbladder, pancreas, and bile ducts. It is the most common type of cancer in the world, and is the second leading cause of cancer-related deaths. Gastroenterology is the branch of medicine that focuses on the diagnosis and treatment of diseases of the digestive system. Gastroenterologists are often the first line of defense in diagnosing and treating gastrointestinal cancer. Gastrointestinal cancer is typically treated with a combination of surgery, chemotherapy, and radiation therapy. In some cases, targeted therapies, such as immunotherapy, may be used. The prognosis for gastrointestinal cancer depends on the stage of the cancer, the type of cancer, and the patient's overall health. There are many companies in the gastrointestinal cancer market, including AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies develop and market drugs and treatments for gastrointestinal cancer, as well as provide support services for patients and their families. Show Less Read more